Clovis Oncology Inc (CLVS)
1.24
+0.03 (+2.48%)
USD |
NASDAQ |
Oct 04, 13:33
Clovis Oncology Price: 1.24 for Oct. 4, 2022
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 03, 2022 | 1.29 | 1.31 | 1.17 | 1.21 | 6.171M |
| Sep 30, 2022 | 1.16 | 1.23 | 1.13 | 1.19 | 1.137M |
| Sep 29, 2022 | 1.16 | 1.190 | 1.10 | 1.16 | 2.016M |
| Sep 28, 2022 | 1.07 | 1.22 | 1.062 | 1.18 | 3.005M |
| Sep 27, 2022 | 1.06 | 1.08 | 1.035 | 1.05 | 1.411M |
| Sep 26, 2022 | 1.12 | 1.14 | 1.02 | 1.05 | 2.483M |
| Sep 23, 2022 | 1.15 | 1.18 | 1.11 | 1.12 | 2.063M |
| Sep 22, 2022 | 1.16 | 1.22 | 1.125 | 1.18 | 2.465M |
| Sep 21, 2022 | 1.17 | 1.23 | 1.15 | 1.16 | 2.756M |
| Sep 20, 2022 | 1.21 | 1.21 | 1.10 | 1.12 | 2.332M |
| Sep 19, 2022 | 1.24 | 1.24 | 1.18 | 1.23 | 1.845M |
| Sep 16, 2022 | 1.35 | 1.37 | 1.21 | 1.26 | 3.971M |
| Sep 15, 2022 | 1.40 | 1.41 | 1.33 | 1.37 | 3.074M |
| Sep 14, 2022 | 1.49 | 1.49 | 1.340 | 1.39 | 4.510M |
| Sep 13, 2022 | 1.45 | 1.52 | 1.36 | 1.49 | 10.36M |
| Sep 12, 2022 | 1.28 | 1.585 | 1.24 | 1.50 | 32.77M |
| Sep 09, 2022 | 1.10 | 1.16 | 1.10 | 1.15 | 1.774M |
| Sep 08, 2022 | 1.11 | 1.18 | 1.10 | 1.10 | 2.270M |
| Sep 07, 2022 | 1.10 | 1.16 | 1.10 | 1.13 | 1.180M |
| Sep 06, 2022 | 1.12 | 1.18 | 1.10 | 1.11 | 1.882M |
| Sep 02, 2022 | 1.20 | 1.21 | 1.12 | 1.13 | 1.770M |
| Sep 01, 2022 | 1.11 | 1.19 | 1.08 | 1.18 | 1.904M |
| Aug 31, 2022 | 1.14 | 1.17 | 1.12 | 1.12 | 1.620M |
| Aug 30, 2022 | 1.20 | 1.22 | 1.10 | 1.11 | 1.857M |
| Aug 29, 2022 | 1.18 | 1.209 | 1.14 | 1.19 | 1.426M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6301
Minimum
May 24 2022
84.58
Maximum
Oct 16 2017
17.16
Average
6.68
Median
Jun 03 2020
Price Benchmarks
| Catalyst Pharmaceuticals Inc | 12.76 |
| Humanigen Inc | 0.1915 |
| Assertio Holdings Inc | 2.33 |
| iRhythm Technologies Inc | 132.64 |
| Bristol-Myers Squibb Co | 71.38 |
Price Related Metrics
| PS Ratio | 1.174 |
| Earnings Yield | -160.5% |
| Market Cap | 179.16M |